Trial · NCT04505592
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants Free of Respiratory Failure | 28 Days | The number of patients free of respiratory failure defined as not requiring high flow nasal cannula, non-rebreather, noninvasive positive pressure ventilation, or mechanical ventilation at 28 days |
| Primary | Number of Participants With Occurrences of Bleeding | 28 days | Safety as assessed by number of participants with occurrences of intracranial bleeding or major bleeding |
| Secondary | Number of Participants With In-hospital Deaths at 14 Days | 14 days | Number of patients who expired in the hospital within the first 14 days of their participation in the study |
| Secondary | Number of Participants With Death at 28 Days | 28 days | Number of participants who expired by 28 days/end of study |
| Secondary | Number of Ventilator-free Days | 28 days | Number of ventilator-free days in 28 days period |
| Secondary | Number of Respiratory Failure-free Days | 28 days | Respiratory failure-free defined as not requiring high flow nasal cannula, non-rebreather, noninvasive positive pressure ventilation, or mechanical ventilation. Number of respiratory failure-free days in 28 days period. |
| Secondary | Number of Vasopressor-free Days | 28 days | Number of vasopressor-free days over 28 days period |
| Secondary | Number of Vasopressor Doses at 24 Hours | 24 hours and 72 hours | |
| Secondary | P/F Ratio | 24 hours and 72 hours | The P/F ratio equals the arterial pO2 ("P") from the ABG divided by the FIO2 ("F") - the fraction (percent) of inspired oxygen that the patient is receiving expressed as a decimal (40% oxygen = FIO2 of 0.40). Ratio of arterial pO2 over fraction of inspired oxygen that the person is receiving. Normal P/F Ratio is ≥ 400. 300 to 200 is considered mild ARDS 200 to 100 is considered moderate ARDS Anything below 100 is considered severe ARDS. |
| Secondary | Number of ICU-free Days | 28 days | Number of days the patient spent outside the ICU |
| Secondary | Hospital Length of Stay | up to 29 days | Length of time the patient spent in the hospital, including ICU |
| Secondary | Number of Participants With New-onset Renal Failure | 28 days | Number of patients who experienced renal failure during the course of the study |
| Secondary | Number of Participants With Need for Renal Replacement Therapy | 28 days | Number of patients who underwent renal replacement treatment for their renal failure |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04505592/registered